health database

  • 文章类型: Systematic Review
    背景:欧洲国家在数据链接整合方面的差异(即,最近强调能够将数据库之间的患者数据匹配)与常规公共卫生活动相匹配。在法国,索赔数据库几乎涵盖了从出生到死亡的整个人口,为数据链接提供了巨大的研究潜力。由于使用通用唯一标识符直接链接个人数据通常受到限制,已经开发了与一组间接密钥标识符的链接,这与链接质量挑战相关,以最大限度地减少链接数据中的错误。
    目的:本系统综述的目的是分析法国有关健康产品使用和护理轨迹的间接数据链接的研究出版物的类型和质量。
    方法:实现了对截至2022年12月31日在PubMed/Medline和Embase数据库中发表的所有论文的全面搜索,涉及链接的法国数据库,重点关注健康产品的使用或护理轨迹。仅包括基于使用间接标识符的研究(即,没有可用于轻松链接数据库的唯一个人标识符)。还实现了对数据链接与质量指标的描述性分析以及对Bohensky框架的评估数据链接研究的坚持。
    结果:总计,选择了16篇论文。在7例(43.8%)病例中在国家一级进行了数据链接,在9例(56.2%)研究中在地方一级进行了数据链接。不同数据库中包含的患者数量以及由数据链接产生的患者数量差异很大,分别,713至75,000名患者和210至31,000名相关患者。研究的疾病主要是慢性疾病和感染。数据链接的目标是多个:估计药物不良反应的风险(ADR;n=6,37.5%),重建患者的护理轨迹(n=5,31.3%),描述治疗用途(n=2,12.5%),为了评估治疗的益处(n=2,12.5%),并评估治疗依从性(n=1,6.3%)。登记处是与法国索赔数据最频繁链接的数据库。没有研究研究过与医院数据仓库的联系,临床试验数据库,或患者自我报告的数据库。在7项(43.8%)研究中,连锁方法是确定性的,4项(25.0%)研究中的概率,5项(31.3%)研究中未指明。联动率主要从80%到90%(11/15报告,73.3%,研究)。坚持Bohensky框架来评估数据链接研究表明,总是对链接的源数据库进行描述,但是没有系统地描述要链接的变量的完成率和准确性。
    结论:这篇综述强调了法国对健康数据关联的兴趣与日俱增。然而,监管,技术,人为限制仍然是其部署的主要障碍。音量,品种,数据的有效性代表了一个真正的挑战,处理这些大数据需要统计分析和人工智能方面的先进专业知识和技能。
    European national disparities in the integration of data linkage (ie, being able to match patient data between databases) into routine public health activities were recently highlighted. In France, the claims database covers almost the whole population from birth to death, offering a great research potential for data linkage. As the use of a common unique identifier to directly link personal data is often limited, linkage with a set of indirect key identifiers has been developed, which is associated with the linkage quality challenge to minimize errors in linked data.
    The aim of this systematic review is to analyze the type and quality of research publications on indirect data linkage on health product use and care trajectories in France.
    A comprehensive search for all papers published in PubMed/Medline and Embase databases up to December 31, 2022, involving linked French database focusing on health products use or care trajectories was realized. Only studies based on the use of indirect identifiers were included (ie, without a unique personal identifier available to easily link the databases). A descriptive analysis of data linkage with quality indicators and adherence to the Bohensky framework for evaluating data linkage studies was also realized.
    In total, 16 papers were selected. Data linkage was performed at the national level in 7 (43.8%) cases or at the local level in 9 (56.2%) studies. The number of patients included in the different databases and resulting from data linkage varied greatly, respectively, from 713 to 75,000 patients and from 210 to 31,000 linked patients. The diseases studied were mainly chronic diseases and infections. The objectives of the data linkage were multiple: to estimate the risk of adverse drug reactions (ADRs; n=6, 37.5%), to reconstruct the patient\'s care trajectory (n=5, 31.3%), to describe therapeutic uses (n=2, 12.5%), to evaluate the benefits of treatments (n=2, 12.5%), and to evaluate treatment adherence (n=1, 6.3%). Registries are the most frequently linked databases with French claims data. No studies have looked at linking with a hospital data warehouse, a clinical trial database, or patient self-reported databases. The linkage approach was deterministic in 7 (43.8%) studies, probabilistic in 4 (25.0%) studies, and not specified in 5 (31.3%) studies. The linkage rate was mainly from 80% to 90% (reported in 11/15, 73.3%, studies). Adherence to the Bohensky framework for evaluating data linkage studies showed that the description of the source databases for the linkage was always performed but that the completion rate and accuracy of the variables to be linked were not systematically described.
    This review highlights the growing interest in health data linkage in France. Nevertheless, regulatory, technical, and human constraints remain major obstacles to their deployment. The volume, variety, and validity of the data represent a real challenge, and advanced expertise and skills in statistical analysis and artificial intelligence are required to treat these big data.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:人工智能(AI)已成为21世纪技术发展的主要驱动力,然而,人们很少关注算法对老年人的偏见。
    目的:本文记录了范围审查的搜索策略和过程,探讨了与年龄相关的偏见如何在AI系统中编码或放大,以及相应的法律和道德含义。
    方法:范围审查遵循Arksey和O\'Malley开发的6阶段方法框架。已在6个数据库中建立了检索策略。我们将通过搜索灰色文献数据库来调查人工智能中年龄歧视的法律含义,有针对性的网站,和流行的搜索引擎,并使用迭代搜索策略。研究符合纳入标准,如果他们是英语,同行评审,以电子方式提供全文,并满足以下两个附加标准之一:(1)在任何应用程序中包括与AI相关的“偏见”(例如,面部识别)和(2)讨论与老年或年龄歧视概念相关的偏见。至少有两名审稿人将独立进行标题,abstract,全文筛选。搜索结果将使用PRISMA-ScR(系统评论的首选报告项目和范围评论的Meta分析扩展)报告指南报告。我们将以结构化的形式绘制数据,并进行主题分析,以突出社会,legal,以及文献中报道的伦理含义。
    结果:在2021年11月进行搜索时,数据库搜索产生了7595条记录。范围审查将于2022年12月完成。
    结论:这些发现将为AI系统中与年龄相关的偏见程度提供跨学科的见解。研究结果将提供基础知识,鼓励多部门合作,以确保人工智能的开发和部署符合道德价值观和人权立法,因为它与老年人和老龄化人口有关。我们将在同行评审的期刊上发布评审结果,并通过研讨会和网络研讨会与利益相关者传播关键结果。
    背景:OSF注册局AMG5P;https://osf.io/amg5p。
    DERR1-10.2196/33211。
    BACKGROUND: Artificial intelligence (AI) has emerged as a major driver of technological development in the 21st century, yet little attention has been paid to algorithmic biases toward older adults.
    OBJECTIVE: This paper documents the search strategy and process for a scoping review exploring how age-related bias is encoded or amplified in AI systems as well as the corresponding legal and ethical implications.
    METHODS: The scoping review follows a 6-stage methodology framework developed by Arksey and O\'Malley. The search strategy has been established in 6 databases. We will investigate the legal implications of ageism in AI by searching grey literature databases, targeted websites, and popular search engines and using an iterative search strategy. Studies meet the inclusion criteria if they are in English, peer-reviewed, available electronically in full text, and meet one of the following two additional criteria: (1) include \"bias\" related to AI in any application (eg, facial recognition) and (2) discuss bias related to the concept of old age or ageism. At least two reviewers will independently conduct the title, abstract, and full-text screening. Search results will be reported using the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) reporting guideline. We will chart data on a structured form and conduct a thematic analysis to highlight the societal, legal, and ethical implications reported in the literature.
    RESULTS: The database searches resulted in 7595 records when the searches were piloted in November 2021. The scoping review will be completed by December 2022.
    CONCLUSIONS: The findings will provide interdisciplinary insights into the extent of age-related bias in AI systems. The results will contribute foundational knowledge that can encourage multisectoral cooperation to ensure that AI is developed and deployed in a manner consistent with ethical values and human rights legislation as it relates to an older and aging population. We will publish the review findings in peer-reviewed journals and disseminate the key results with stakeholders via workshops and webinars.
    BACKGROUND: OSF Registries AMG5P; https://osf.io/amg5p.
    UNASSIGNED: DERR1-10.2196/33211.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:本范围审查探讨并总结了有关使用聊天机器人支持和促进非洲健康的现有文献。
    目的:文献综述的主要目的是了解在什么情况下,聊天机器人在非洲被有效地用于健康,如何开发聊天机器人以达到最佳效果以及如何对其进行评估。第二个目标是为其他聊天机器人确定潜在的经验教训和良好做法。该评论还指出了未来在非洲使用聊天机器人进行健康研究的方向。
    方法:它使用布尔搜索方法来回答四个问题:关于非洲聊天机器人的文献告诉我们有关设计的信息,该技术在该地区的医疗保健部门和社会中的使用和用户体验?这些数据在多大程度上告诉我们有关政策问题的信息,access,关于非洲医疗保健系统和服务中聊天机器人的伦理和监管问题?创新的测量和评估框架在哪里出现,以及在非洲医疗保健中使用聊天机器人的形式?这些数据提供了哪些关于非洲医疗保健部门聊天机器人景观的新问题或未来的见解,包括需要进一步研究的领域?
    结果:审查得出的结论是,当前数据不足以有效地支持聊天机器人在非洲。然而,它确实表明了当前可用的聊天机器人文献类型以及差距所在的位置,并为未来的研究指明了方向。它提供了对流行聊天机器人的见解,以及通过语言考虑使它们可访问的需求,平台选择和用户信任,以及稳健的评估框架对评估其影响的重要性。
    结论:需要将对聊天机器人的研究扩展到现有的和有限的健康学科和功能之外,以及解决围绕道德和包容性的问题,特别是来自农村地区和弱势群体的用户。显然还需要将研究扩展到非洲大陆的新国家。
    背景:
    This scoping review explores and summarizes the existing literature on the use of chatbots to support and promote health in Africa.
    The primary aim was to learn where, and under what circumstances, chatbots have been used effectively for health in Africa; how chatbots have been developed to the best effect; and how they have been evaluated by looking at literature published between 2017 and 2022. A secondary aim was to identify potential lessons and best practices for others chatbots. The review also aimed to highlight directions for future research on the use of chatbots for health in Africa.
    Using the 2005 Arksey and O\'Malley framework, we used a Boolean search to broadly search literature published between January 2017 and July 2022. Literature between June 2021 and July 2022 was identified using Google Scholar, EBSCO information services-which includes the African HealthLine, PubMed, MEDLINE, PsycInfo, Cochrane, Embase, Scopus, and Web of Science databases-and other internet sources (including gray literature). The inclusion criteria were literature about health chatbots in Africa published in journals, conference papers, opinion, or white papers.
    In all, 212 records were screened, and 12 articles met the inclusion criteria. Results were analyzed according to the themes they covered. The themes identified included the purpose of the chatbot as either providing an educational or information-sharing service or providing a counselling service. Accessibility as a result of either technical restrictions or language restrictions was also noted. Other themes that were identified included the need for the consideration of trust, privacy and ethics, and evaluation.
    The findings demonstrate that current data are insufficient to show whether chatbots are effectively supporting health in the region. However, the review does reveal insights into popular chatbots and the need to make them accessible through language considerations, platform choice, and user trust, as well as the importance of robust evaluation frameworks to assess their impact. The review also provides recommendations on the direction of future research.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:移动健康(mHealth)应用程序的使用在全球范围内迅速增加。越来越多的机构和组织制定法规和准则,以实现基于证据的安全使用。在德国,满足预定义标准的mHealth应用程序(DigitaleGesundheitsanwendungen[DiGA])可以规定并由德国法定健康保险计划报销。由于DiGA分布的增加,问题和障碍应该得到特别关注。
    目的:本研究旨在确定与使用符合DiGA标准的mHealth应用程序相关的问题和障碍。
    方法:本范围审查将遵循已发布的方法学框架和PRISMA-Scr(系统审查的首选报告项目和范围审查的Meta扩展分析)标准。电子数据库(MEDLINE,EMBASE,PsycINFO,和JMIR),相关文章的参考列表,和灰色文献来源将被搜索。两名审稿人将通过两个阶段(标题和摘要以及全文)筛选过程来评估文章的资格。本研究仅包括与满足DiGA标准的mHealth应用程序相关的问题和障碍。将使用MAXQDA对确定的研究进行分类和分析。
    结果:本范围审查概述了现有证据,并确定了与DiGA相关的问题和障碍的研究空白。计划将结果提交给索引,2022年第一季度的同行评审期刊。
    结论:这是第一次审查,以确定与使用mHealth应用程序符合德国对DiGA的定义有关的问题和障碍。然而,这些发现也可以应用于其他环境和医疗保健系统。
    UNASSIGNED:DERR1-10.2196/32702。
    BACKGROUND: The use of mobile health (mHealth) apps is increasing rapidly worldwide. More and more institutions and organizations develop regulations and guidelines to enable an evidence-based and safe use. In Germany, mHealth apps fulfilling predefined criteria (Digitale Gesundheitsanwendungen [DiGA]) can be prescribed and are reimbursable by the German statutory health insurance scheme. Due to the increasing distribution of DiGA, problems and barriers should receive special attention.
    OBJECTIVE: This study aims to identify the relevant problems and barriers related to the use of mHealth apps fulfilling the criteria of DiGA.
    METHODS: This scoping review will follow published methodological frameworks and the PRISMA-Scr (Preferred Reporting Items for Systematic Reviews and Meta-analyses Extension for Scoping Reviews) criteria. Electronic databases (MEDLINE, EMBASE, PsycINFO, and JMIR), reference lists of relevant articles, and grey literature sources will be searched. Two reviewers will assess the eligibility of the articles by a two-stage (title and abstract as well as full text) screening process. Only problems and barriers related to mHealth apps fulfilling the criteria of DiGA are included for this research. The identified studies will be categorized and analyzed with MAXQDA.
    RESULTS: This scoping review gives an overview of the available evidence and identifies research gaps regarding problems and barriers related to DiGA. The results are planned to be submitted to an indexed, peer-reviewed journal in the first quarter of 2022.
    CONCLUSIONS: This is the first review to identify the problems and barriers related to the use of mHealth apps fulfilling the German definition of DiGA. Nevertheless, the findings can be applied to other contexts and health care systems as well.
    UNASSIGNED: DERR1-10.2196/32702.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:了解消费者在怀孕轨迹的所有阶段的健康信息需求对于发展使他们能够获取高质量的健康信息的机制至关重要,定制,和外行人友好的健康信息。
    目的:本研究的目的是确定妊娠相关消费者信息需求和来自不同来源的可用信息的研究差距。
    方法:我们对CINAHL进行了系统评价,科克伦,PubMed,和WebofScience获取2009年至2019年发表的相关文章。使用关键评估技能计划评估了所包含文章的质量。对这些文章进行了描述性数据分析。根据审查结果,我们开发了妊娠信息需求本体论(PINO),并在GitHub和BioPortal中公开发布.
    结果:来自9个国家的总共33篇文章符合本综述的纳入标准,其中大多数发布时间不早于2016年。大多数研究要么是描述性的(9/33,27%),面试(7/33,21%),或调查/问卷(7/33,21%);20篇文章提到消费者“怀孕相关信息需求”。一半(9/18,50%)的人类受试者研究在美国进行。超过三分之一(13/33,39%)的所有研究集中在怀孕期间阶段;只有一项研究(1/33,3%)是关于怀孕的所有阶段。最常见的消费者信息需求与人工交付有关(9/20,45%),孕期用药(6/20,30%),新生儿护理(5/20,25%),和实验室测试(6/20,30%)。最常见的信息来源是互联网(15/24,63%)。PINO由267个类组成,555公理,和271个子类关系。
    结论:只有少数文章评估了获取妊娠相关信息的障碍和每个信息来源的质量;需要进一步的工作。还需要今后的工作来解决所需信息与现有信息之间的差距。
    BACKGROUND: Understanding consumers\' health information needs across all stages of the pregnancy trajectory is crucial to the development of mechanisms that allow them to retrieve high-quality, customized, and layperson-friendly health information.
    OBJECTIVE: The objective of this study was to identify research gaps in pregnancy-related consumer information needs and available information from different sources.
    METHODS: We conducted a systematic review of CINAHL, Cochrane, PubMed, and Web of Science for relevant articles that were published from 2009 to 2019. The quality of the included articles was assessed using the Critical Appraisal Skills Program. A descriptive data analysis was performed on these articles. Based on the review result, we developed the Pregnancy Information Needs Ontology (PINO) and made it publicly available in GitHub and BioPortal.
    RESULTS: A total of 33 articles from 9 countries met the inclusion criteria for this review, of which the majority were published no earlier than 2016. Most studies were either descriptive (9/33, 27%), interviews (7/33, 21%), or surveys/questionnaires (7/33, 21%); 20 articles mentioned consumers\' pregnancy-related information needs. Half (9/18, 50%) of the human-subject studies were conducted in the United States. More than a third (13/33, 39%) of all studies focused on during-pregnancy stage; only one study (1/33, 3%) was about all stages of pregnancy. The most frequent consumer information needs were related to labor delivery (9/20, 45%), medication in pregnancy (6/20, 30%), newborn care (5/20, 25%), and lab tests (6/20, 30%). The most frequently available source of information was the internet (15/24, 63%). PINO consists of 267 classes, 555 axioms, and 271 subclass relationships.
    CONCLUSIONS: Only a few articles assessed the barriers to access to pregnancy-related information and the quality of each source of information; further work is needed. Future work is also needed to address the gaps between the information needed and the information available.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号